COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up

A Tajbakhsh, SM Gheibi Hayat… - Expert review of anti …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has the characteristics of
high transmission, diverse clinical manifestations, and a long incubation period. In addition …

Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future

OO Ogunleye, D Basu, D Mueller, J Sneddon… - Frontiers in …, 2020 - frontiersin.org
Background The COVID-19 pandemic has already claimed considerable lives. There are
major concerns in Africa due to existing high prevalence rates for both infectious and non …

Variants in ACE2; potential influences on virus infection and COVID-19 severity

B Bakhshandeh, SG Sorboni, AR Javanmard… - Infection, Genetics and …, 2021 - Elsevier
The third pandemic of coronavirus infection, called COVID-19 disease, was first detected in
November 2019th. Various determinants of disease progression such as age, sex, virus …

Increased plasma heparanase activity in COVID-19 patients

B Buijsers, C Yanginlar, A de Nooijer… - Frontiers in …, 2020 - frontiersin.org
Reports suggest a role of endothelial dysfunction and loss of endothelial barrier function in
COVID-19. It is well established that the endothelial glycocalyx-degrading enzyme …

Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story

A Gasmi, M Peana, S Noor, R Lysiuk, A Menzel… - Applied microbiology …, 2021 - Springer
The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …

A systematic review of systematic reviews on the COVID-19 pandemic

ZN Hatmi - SN comprehensive clinical medicine, 2021 - Springer
COVID-19 a systemic inflammation involving multiple organs, affecting all age groups, with
high mortality rate, severe adverse outcomes, and high economic burden need to be …

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

A Di Castelnuovo, S Costanzo, A Antinori… - European Journal of …, 2020 - Elsevier
Background Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19.
Objective We set-up a multicenter Italian collaboration to investigate the relationship …

COVID-19 mortality risk factors in older people in a long-term care center

E Heras, P Garibaldi, M Boix, O Valero… - European geriatric …, 2021 - Springer
Purpose Despite high rates of COVID-19 infection and increased related mortality have
been reported among older adults admitted in long-term care facilities, a limited amount of …

[HTML][HTML] Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season

C Jiang, X Yao, Y Zhao, J Wu, P Huang, C Pan… - Microbes and …, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to sweep the
world, causing infection of millions and death of hundreds of thousands. The respiratory …

SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review

JAC Nascimento Junior, AM Santos… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Coronavirus has been responsible for several virus outbreaks since 2003,
caused by SARS-CoV-1, MERS-CoV, and currently SARS-CoV-2 (COVID-19), the causative …